TR201200214A2 - Alendronat içeren farmasötik granüller. - Google Patents

Alendronat içeren farmasötik granüller.

Info

Publication number
TR201200214A2
TR201200214A2 TR2012/00214A TR201200214A TR201200214A2 TR 201200214 A2 TR201200214 A2 TR 201200214A2 TR 2012/00214 A TR2012/00214 A TR 2012/00214A TR 201200214 A TR201200214 A TR 201200214A TR 201200214 A2 TR201200214 A2 TR 201200214A2
Authority
TR
Turkey
Prior art keywords
granules containing
pharmaceutical granules
containing alendronate
alendronate
pharmaceutical
Prior art date
Application number
TR2012/00214A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2012/00214A priority Critical patent/TR201200214A2/tr
Publication of TR201200214A2 publication Critical patent/TR201200214A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş kemik erimesi ve ilişkili hastalıkların önlenmesinde ve tedavisinde kullanılmak üzere alendronat içeren farmasötik formülasyonlara ilişkindir.
TR2012/00214A 2011-01-06 2012-01-06 Alendronat içeren farmasötik granüller. TR201200214A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2012/00214A TR201200214A2 (tr) 2011-01-06 2012-01-06 Alendronat içeren farmasötik granüller.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2011/00153A TR201100153A2 (tr) 2011-01-06 2011-01-06 Efervesan bifosfonat formülasyonları.
TR2012/00214A TR201200214A2 (tr) 2011-01-06 2012-01-06 Alendronat içeren farmasötik granüller.

Publications (1)

Publication Number Publication Date
TR201200214A2 true TR201200214A2 (tr) 2012-07-23

Family

ID=45771873

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2011/00153A TR201100153A2 (tr) 2011-01-06 2011-01-06 Efervesan bifosfonat formülasyonları.
TR2012/00215A TR201200215A2 (tr) 2011-01-06 2012-01-06 Geliştirilmiş farmasötik formülasyonlar.
TR2012/00216A TR201200216A2 (tr) 2011-01-06 2012-01-06 Kombine tedavi paketi.
TR2012/00214A TR201200214A2 (tr) 2011-01-06 2012-01-06 Alendronat içeren farmasötik granüller.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
TR2011/00153A TR201100153A2 (tr) 2011-01-06 2011-01-06 Efervesan bifosfonat formülasyonları.
TR2012/00215A TR201200215A2 (tr) 2011-01-06 2012-01-06 Geliştirilmiş farmasötik formülasyonlar.
TR2012/00216A TR201200216A2 (tr) 2011-01-06 2012-01-06 Kombine tedavi paketi.

Country Status (3)

Country Link
EP (1) EP2661257B1 (tr)
TR (4) TR201100153A2 (tr)
WO (1) WO2012093978A1 (tr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196315B (it) 1984-10-29 1988-11-16 Gentili Ist Spa Procedimento per la preparazione di acidi difosfonici
TR200900880A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik bileşimler.

Also Published As

Publication number Publication date
TR201100153A2 (tr) 2012-07-23
WO2012093978A1 (en) 2012-07-12
TR201200215A2 (tr) 2012-07-23
EP2661257A1 (en) 2013-11-13
EP2661257B1 (en) 2017-11-15
TR201200216A2 (tr) 2012-07-23

Similar Documents

Publication Publication Date Title
EP3466408C0 (en) LIQUID PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A DISEASE OF THE POSTERIOR EYE
PH12017501306A1 (en) Inhibitors of histone demethylases
EA201590165A1 (ru) Сдерживающие злоупотребление фармацевтические композиции для контролируемого высвобождения
TW201129382A (en) Antibody formulation and therapeutic regimens
BR112015010663A2 (pt) formas de dosagem de ruxolitinib de liberação sustentada
IN2014MN00948A (tr)
EA201991484A1 (ru) Лекарственные формы энзалутамида
TN2012000465A1 (en) Derivatives of 1-amino-2-cyclopropylethylboronic acid
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
EA201591166A1 (ru) Ингибиторы аутотаксина
HN2012000023A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
UY33863A (es) Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer
UA116999C2 (uk) Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить
IN2014MN00987A (tr)
EP2415763A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF GLAUCOMA
MX363462B (es) Diagnostico, prevencion y tratamiento de enfermedades de la articulacion.
HUE053409T2 (hu) Ortopédiai szék a gerincbetegségek kezelésére és megelõzésére
EP2849738C0 (en) HIGH PENETRATION PRODRUG COMPOSITIONS AND ASSOCIATED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY CONDITIONS
PL2582366T3 (pl) Kombinacja farmaceutyczna do leczenia bólu
MX349224B (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa.
MX344846B (es) Combinacion de granulos cargados activos con activos adicionales.
EP2769973A4 (en) INGENANE TYPE DITERPENE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF VIRAL INFECTIOUS DISEASES CONTAINING THE SAME
EA201201296A1 (ru) Способы лечения диабетических язв стопы
NZ702253A (en) Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors
TR201004464A2 (tr) Kemik erimesi için formülasyon.